Celerion

About
What does Celerion do?
Celerion is a global leader in clinical pharmacology and bioanalytical sciences, providing services to pharmaceutical and biotechnology companies to help bring new therapies to patients. They focus on early-stage drug development, offering expertise in bioanalytical testing, clinical pharmacology studies, and data management.
What is Celerion's revenue?
StartupHub estimates Celerion's annual revenue at $180.1M (range $100.2M to $519.3M, 69% confidence), based on comparable companies in the sector.
What is Celerion's valuation?
StartupHub estimates Celerion's effective valuation at $298.1M (range $100.8M to $665.3M, 56% confidence), based on comparable companies in the sector.
How much funding has Celerion raised?
Celerion has raised a total of $45M in funding. The most recent round on record is Majority Investment.
Where is Celerion headquartered?
Celerion is headquartered in Lincoln, Nebraska, USA.
When was Celerion founded?
Celerion was founded in 1975.
What industry does Celerion operate in?
Celerion operates in Biotechnology, Pharmaceuticals, Healthcare, Life Sciences, Biotech, MedTech.
How many employees does Celerion have?
Celerion has approximately 1162 people on record.
No comments yet. Be the first to share your take.